Overview
From a portfolio lens, USDS ($9.72B) and Injective ($490.41M) offer different beta to bitcoin cycles. The overview below keeps the facts first and the narrative second.
Quick winners
Full comparison
| Metric | USDS | INJ |
|---|---|---|
| Price | $1.00 | $5.13 |
| Market Cap | $9.72B | $490.41M |
| FDV | — | — |
| Volume 24h | $224,458.65 | $2.59M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 12.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USDS | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.01% | +3.91% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USDS | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (58.20 vs 48.70) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | USDS | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USDS
Injective
Pros and cons
Pros of USDS
- USDS has an established coin page footprint on PEPS for continuous monitoring.
- Composite PEPS readings for USDS can surface clearer module agreement during trend phases.
- USDS often anchors narratives that attract sustained media and analyst coverage.
- Higher ranking for USDS can translate into tighter spreads on major venues.
Cons of USDS
- Regulatory or macro headlines can hit USDS harder simply because it is more visible.
- Crowded positioning around USDS sometimes amplifies squeeze or flush risk.
- Large-cap status for USDS can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- Diversifying versus USDS with Injective can change portfolio factor exposure.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Trend failures on Injective often travel faster than on more established assets.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
If you weight capitalization and liquidity, USDS looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put USDS at $1.00 and Injective at $5.13. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, USDS or Injective?
“Better” depends on horizon and risk. USDS leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USDS or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USDS and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.